CD1D and ovarian carcinoma: Webb et al. proved that a high concentration of GD3 in ovarian cancer-associated ascites could compete with endogenous stimulatory ligands to bind to CD1d for suppression of natural killer T (NKT) cells in ovarian cancer, which was correlated with poor prognosis (Webb et al., 2012).